No Data
Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement
Surgery Partners (NASDAQ:SGRY) Shareholder Returns Have Been Enviable, Earning 417% in 5 Years
Surgery Partners Price Target Maintained With a $50.00/Share by Benchmark
Benchmark Reiterates Buy on Surgery Partners, Maintains $50 Price Target
Benchmark Co. Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $50
Benchmark Co. analyst Bill Sutherland maintains $Surgery Partners(SGRY.US)$ with a buy rating, and maintains the target price at $50.According to TipRanks data, the analyst has a success rate of 38.4%
Benchmark Co. Sticks to Their Buy Rating for Surgery Partners (SGRY)